APO Research
Talk to an analyst

APO RESEARCH · REPORT

Breast AI-assisted Diagnosis Software

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Breast AI-assisted Diagnosis Software Market Analysis and Forecast 2026-2032

6 March 2026197 pages

Choose your research edition.

Industry ResearchBreast AI-assisted Diagnosis Software Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Breast AI-assisted Diagnosis Software Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Breast AI-assisted Diagnosis Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Breast AI-assisted Diagnosis Software Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Breast AI-assisted Diagnosis Software Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Breast AI-assisted Diagnosis Software market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Breast AI-assisted Diagnosis Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Breast AI-assisted Diagnosis Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Breast AI-assisted Diagnosis Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Breast AI-assisted Diagnosis Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Breast AI-assisted Diagnosis Software include Yizhun, Sense Time, United Imaging, Huiying Medical, BioMind, Infervision, Demetics Medical, GE HealthCare and Kheiron, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Breast AI-assisted Diagnosis Software, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Breast AI-assisted Diagnosis Software, also provides the revenue of main regions and countries. Of the upcoming market potential for Breast AI-assisted Diagnosis Software, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Breast AI-assisted Diagnosis Software revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Breast AI-assisted Diagnosis Software market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Breast AI-assisted Diagnosis Software revenue, projected growth trends, production technology, application and end-user industry.

Breast AI-assisted Diagnosis Software Segment by Company

Yizhun

Sense Time

United Imaging

Huiying Medical

BioMind

Infervision

Demetics Medical

GE HealthCare

Kheiron

Hologic

Densitas

Lunit Inc.

Breast AI-assisted Diagnosis Software Segment by Type

Cloud-based

On-Primes

Breast AI-assisted Diagnosis Software Segment by Application

Hospital

Clinic

Imaging Center

Breast AI-assisted Diagnosis Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Breast AI-assisted Diagnosis Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Breast AI-assisted Diagnosis Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Breast AI-assisted Diagnosis Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Breast AI-assisted Diagnosis Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Breast AI-assisted Diagnosis Software company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Breast AI-assisted Diagnosis Software revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Breast AI-assisted Diagnosis Software Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Cloud-based Major Player Table 3. On-Primes Major Player Table 4. Global Breast AI-assisted Diagnosis Software Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Player Table 6. Clinic Major Player Table 7. Imaging Center Major Player Table 8. Breast AI-assisted Diagnosis Software Industry Trends Table 9. Breast AI-assisted Diagnosis Software Industry Drivers Table 10. Breast AI-assisted Diagnosis Software Industry Opportunities and Challenges Table 11. Breast AI-assisted Diagnosis Software Industry Restraints Table 12. Global Breast AI-assisted Diagnosis Software Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Breast AI-assisted Diagnosis Software Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Breast AI-assisted Diagnosis Software Market Share by Region (2021-2026) Table 15. Global Breast AI-assisted Diagnosis Software Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Breast AI-assisted Diagnosis Software Market Share by Region (2027-2032) Table 17. Global Breast AI-assisted Diagnosis Software Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Breast AI-assisted Diagnosis Software Revenue Market Share by Players (2021-2026) Table 19. Global Breast AI-assisted Diagnosis Software Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Breast AI-assisted Diagnosis Software Key Players Headquarters & Area Served Table 21. Global Breast AI-assisted Diagnosis Software Players, Product Type & Application Table 22. Global Breast AI-assisted Diagnosis Software Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Breast AI-assisted Diagnosis Software by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Breast AI-assisted Diagnosis Software Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Breast AI-assisted Diagnosis Software Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Breast AI-assisted Diagnosis Software Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Breast AI-assisted Diagnosis Software Revenue Market Share by Type (2021-2026) Table 29. Global Breast AI-assisted Diagnosis Software Revenue Market Share by Type (2027-2032) Table 30. Global Breast AI-assisted Diagnosis Software Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Breast AI-assisted Diagnosis Software Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Breast AI-assisted Diagnosis Software Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Breast AI-assisted Diagnosis Software Revenue Market Share by Application (2021-2026) Table 34. Global Breast AI-assisted Diagnosis Software Revenue Market Share by Application (2027-2032) Table 35. Yizhun Company Information Table 36. Yizhun Business Overview Table 37. Yizhun Breast AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Yizhun Breast AI-assisted Diagnosis Software Product Portfolio Table 39. Yizhun Recent Development Table 40. Sense Time Company Information Table 41. Sense Time Business Overview Table 42. Sense Time Breast AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Sense Time Breast AI-assisted Diagnosis Software Product Portfolio Table 44. Sense Time Recent Development Table 45. United Imaging Company Information Table 46. United Imaging Business Overview Table 47. United Imaging Breast AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. United Imaging Breast AI-assisted Diagnosis Software Product Portfolio Table 49. United Imaging Recent Development Table 50. Huiying Medical Company Information Table 51. Huiying Medical Business Overview Table 52. Huiying Medical Breast AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Huiying Medical Breast AI-assisted Diagnosis Software Product Portfolio Table 54. Huiying Medical Recent Development Table 55. BioMind Company Information Table 56. BioMind Business Overview Table 57. BioMind Breast AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. BioMind Breast AI-assisted Diagnosis Software Product Portfolio Table 59. BioMind Recent Development Table 60. Infervision Company Information Table 61. Infervision Business Overview Table 62. Infervision Breast AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Infervision Breast AI-assisted Diagnosis Software Product Portfolio Table 64. Infervision Recent Development Table 65. Demetics Medical Company Information Table 66. Demetics Medical Business Overview Table 67. Demetics Medical Breast AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Demetics Medical Breast AI-assisted Diagnosis Software Product Portfolio Table 69. Demetics Medical Recent Development Table 70. GE HealthCare Company Information Table 71. GE HealthCare Business Overview Table 72. GE HealthCare Breast AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. GE HealthCare Breast AI-assisted Diagnosis Software Product Portfolio Table 74. GE HealthCare Recent Development Table 75. Kheiron Company Information Table 76. Kheiron Business Overview Table 77. Kheiron Breast AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Kheiron Breast AI-assisted Diagnosis Software Product Portfolio Table 79. Kheiron Recent Development Table 80. Hologic Company Information Table 81. Hologic Business Overview Table 82. Hologic Breast AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Hologic Breast AI-assisted Diagnosis Software Product Portfolio Table 84. Hologic Recent Development Table 85. Densitas Company Information Table 86. Densitas Business Overview Table 87. Densitas Breast AI-assisted Diagnosis Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. Densitas Breast AI-assisted Diagnosis Software Product Portfolio Table 89. Densitas Recent Development Table 90. Lunit Inc. Company Information Table 91. Lunit Inc. Business Overview Table 92. Lunit Inc. Breast AI-assisted Diagnosis Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Lunit Inc. Breast AI-assisted Diagnosis Software Product Portfolio Table 94. Lunit Inc. Recent Development Table 95. North America Breast AI-assisted Diagnosis Software Revenue by Type (2021-2026) & (US$ Million) Table 96. North America Breast AI-assisted Diagnosis Software Revenue by Type (2027-2032) & (US$ Million) Table 97. North America Breast AI-assisted Diagnosis Software Revenue by Application (2021-2026) & (US$ Million) Table 98. North America Breast AI-assisted Diagnosis Software Revenue by Application (2027-2032) & (US$ Million) Table 99. North America Breast AI-assisted Diagnosis Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 100. North America Breast AI-assisted Diagnosis Software Revenue by Country (2021-2026) & (US$ Million) Table 101. North America Breast AI-assisted Diagnosis Software Revenue by Country (US$ Million) & (2027-2032) Table 102. Europe Breast AI-assisted Diagnosis Software Revenue by Type (2021-2026) & (US$ Million) Table 103. Europe Breast AI-assisted Diagnosis Software Revenue by Type (2027-2032) & (US$ Million) Table 104. Europe Breast AI-assisted Diagnosis Software Revenue by Application (2021-2026) & (US$ Million) Table 105. Europe Breast AI-assisted Diagnosis Software Revenue by Application (2027-2032) & (US$ Million) Table 106. Europe Breast AI-assisted Diagnosis Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 107. Europe Breast AI-assisted Diagnosis Software Revenue by Country (2021-2026) & (US$ Million) Table 108. Europe Breast AI-assisted Diagnosis Software Revenue by Country (US$ Million) & (2027-2032) Table 109. China Breast AI-assisted Diagnosis Software Revenue by Type (2021-2026) & (US$ Million) Table 110. China Breast AI-assisted Diagnosis Software Revenue by Type (2027-2032) & (US$ Million) Table 111. China Breast AI-assisted Diagnosis Software Revenue by Application (2021-2026) & (US$ Million) Table 112. China Breast AI-assisted Diagnosis Software Revenue by Application (2027-2032) & (US$ Million) Table 113. Asia Breast AI-assisted Diagnosis Software Revenue by Type (2021-2026) & (US$ Million) Table 114. Asia Breast AI-assisted Diagnosis Software Revenue by Type (2027-2032) & (US$ Million) Table 115. Asia Breast AI-assisted Diagnosis Software Revenue by Application (2021-2026) & (US$ Million) Table 116. Asia Breast AI-assisted Diagnosis Software Revenue by Application (2027-2032) & (US$ Million) Table 117. Asia Breast AI-assisted Diagnosis Software Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 118. Asia Breast AI-assisted Diagnosis Software Revenue by Region (US$ Million) & (2021-2026) Table 119. Asia Breast AI-assisted Diagnosis Software Revenue by Region (US$ Million) & (2027-2032) Table 120. SAMEA Breast AI-assisted Diagnosis Software Revenue by Type (2021-2026) & (US$ Million) Table 121. SAMEA Breast AI-assisted Diagnosis Software Revenue by Type (2027-2032) & (US$ Million) Table 122. SAMEA Breast AI-assisted Diagnosis Software Revenue by Application (2021-2026) & (US$ Million) Table 123. SAMEA Breast AI-assisted Diagnosis Software Revenue by Application (2027-2032) & (US$ Million) Table 124. SAMEA Breast AI-assisted Diagnosis Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 125. SAMEA Breast AI-assisted Diagnosis Software Revenue by Country (2021-2026) & (US$ Million) Table 126. SAMEA Breast AI-assisted Diagnosis Software Revenue by Country (US$ Million) & (2027-2032) Table 127. Research Programs/Design for This Report Table 128. Authors List of This Report Table 129. Secondary Sources Table 130. Primary Sources List of Figures Figure 1. Breast AI-assisted Diagnosis Software Image Figure 2. Global Breast AI-assisted Diagnosis Software Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Breast AI-assisted Diagnosis Software Market Size Share 2021 VS 2025 VS 2032 Figure 4. Cloud-based Image Figure 5. On-Primes Image Figure 6. Global Breast AI-assisted Diagnosis Software Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Breast AI-assisted Diagnosis Software Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Imaging Center Image Figure 11. Global Breast AI-assisted Diagnosis Software Market Size (US$ Million) & (2021-2032) Figure 12. Global Breast AI-assisted Diagnosis Software Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Breast AI-assisted Diagnosis Software Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Breast AI-assisted Diagnosis Software Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Breast AI-assisted Diagnosis Software Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Breast AI-assisted Diagnosis Software Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Breast AI-assisted Diagnosis Software Revenue Market Share by Type (2021-2032) Figure 19. Global Breast AI-assisted Diagnosis Software Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Breast AI-assisted Diagnosis Software Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Breast AI-assisted Diagnosis Software Revenue Market Share by Application (2021-2032) Figure 22. North America Breast AI-assisted Diagnosis Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Breast AI-assisted Diagnosis Software Revenue Share by Type (2021-2032) Figure 24. North America Breast AI-assisted Diagnosis Software Revenue Share by Application (2021-2032) Figure 25. North America Breast AI-assisted Diagnosis Software Revenue Share by Country (2021-2032) Figure 26. United States Breast AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Breast AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Breast AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Breast AI-assisted Diagnosis Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Breast AI-assisted Diagnosis Software Revenue Share by Type (2021-2032) Figure 31. Europe Breast AI-assisted Diagnosis Software Revenue Share by Application (2021-2032) Figure 32. Europe Breast AI-assisted Diagnosis Software Revenue Share by Country (2021-2032) Figure 33. Germany Breast AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Breast AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Breast AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Breast AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Breast AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Breast AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Breast AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Breast AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Breast AI-assisted Diagnosis Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Breast AI-assisted Diagnosis Software Revenue Share by Type (2021-2032) Figure 43. China Breast AI-assisted Diagnosis Software Revenue Share by Application (2021-2032) Figure 44. Asia Breast AI-assisted Diagnosis Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Breast AI-assisted Diagnosis Software Revenue Share by Type (2021-2032) Figure 46. Asia Breast AI-assisted Diagnosis Software Revenue Share by Application (2021-2032) Figure 47. Asia Breast AI-assisted Diagnosis Software Revenue Share by Region (2021-2032) Figure 48. Japan Breast AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Breast AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Breast AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Breast AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Breast AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Breast AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Breast AI-assisted Diagnosis Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Breast AI-assisted Diagnosis Software Revenue Share by Type (2021-2032) Figure 56. SAMEA Breast AI-assisted Diagnosis Software Revenue Share by Application (2021-2032) Figure 57. SAMEA Breast AI-assisted Diagnosis Software Revenue Share by Country (2021-2032) Figure 58. Brazil Breast AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Breast AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Breast AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Breast AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Breast AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Breast AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Breast AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Breast AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Breast AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Breast AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Breast AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Cloud-based
  • On-Primes
Applications
  • Hospital
  • Clinic
  • Imaging Center
Companies covered
  • Yizhun
  • Sense Time
  • United Imaging
  • Huiying Medical
  • BioMind
  • Infervision
  • Demetics Medical
  • GE HealthCare
  • Kheiron
  • Hologic
  • Densitas
  • Lunit Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Breast AI-assisted Diagnosis Software Market by Type
  3. 1.2.1 Global Breast AI-assisted Diagnosis Software Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Cloud-based
  5. 1.2.3 On-Primes
  6. 1.3 Breast AI-assisted Diagnosis Software Market by Application
  7. 1.3.1 Global Breast AI-assisted Diagnosis Software Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.3.4 Imaging Center
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Breast AI-assisted Diagnosis Software Market Dynamics
  1. 2.1 Breast AI-assisted Diagnosis Software Industry Trends
  2. 2.2 Breast AI-assisted Diagnosis Software Industry Drivers
  3. 2.3 Breast AI-assisted Diagnosis Software Industry Opportunities and Challenges
  4. 2.4 Breast AI-assisted Diagnosis Software Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Breast AI-assisted Diagnosis Software Market Perspective (2021-2032)
  2. 3.2 Global Breast AI-assisted Diagnosis Software Growth Trends by Region
  3. 3.2.1 Global Breast AI-assisted Diagnosis Software Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Breast AI-assisted Diagnosis Software Market Size by Region (2021-2026)
  5. 3.2.3 Global Breast AI-assisted Diagnosis Software Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Breast AI-assisted Diagnosis Software Revenue by Players
  2. 4.1.1 Global Breast AI-assisted Diagnosis Software Revenue by Players (2021-2026)
  3. 4.1.2 Global Breast AI-assisted Diagnosis Software Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Breast AI-assisted Diagnosis Software Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Breast AI-assisted Diagnosis Software Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Breast AI-assisted Diagnosis Software Key Players Headquarters & Area Served
  7. 4.4 Global Breast AI-assisted Diagnosis Software Players, Product Type & Application
  8. 4.5 Global Breast AI-assisted Diagnosis Software Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Breast AI-assisted Diagnosis Software Market CR5 and HHI
  11. 4.6.3 2025 Breast AI-assisted Diagnosis Software Tier 1, Tier 2, and Tier 3
5 Breast AI-assisted Diagnosis Software Market Size by Type
  1. 5.1 Global Breast AI-assisted Diagnosis Software Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Breast AI-assisted Diagnosis Software Revenue by Type (2021-2032)
  3. 5.3 Global Breast AI-assisted Diagnosis Software Revenue Market Share by Type (2021-2032)
6 Breast AI-assisted Diagnosis Software Market Size by Application
  1. 6.1 Global Breast AI-assisted Diagnosis Software Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Breast AI-assisted Diagnosis Software Revenue by Application (2021-2032)
  3. 6.3 Global Breast AI-assisted Diagnosis Software Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Yizhun
  2. 7.1.1 Yizhun Company Information
  3. 7.1.2 Yizhun Business Overview
  4. 7.1.3 Yizhun Breast AI-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Yizhun Breast AI-assisted Diagnosis Software Product Portfolio
  6. 7.1.5 Yizhun Recent Developments
  7. 7.2 Sense Time
  8. 7.2.1 Sense Time Company Information
  9. 7.2.2 Sense Time Business Overview
  10. 7.2.3 Sense Time Breast AI-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Sense Time Breast AI-assisted Diagnosis Software Product Portfolio
  12. 7.2.5 Sense Time Recent Developments
  13. 7.3 United Imaging
  14. 7.3.1 United Imaging Company Information
  15. 7.3.2 United Imaging Business Overview
  16. 7.3.3 United Imaging Breast AI-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  17. 7.3.4 United Imaging Breast AI-assisted Diagnosis Software Product Portfolio
  18. 7.3.5 United Imaging Recent Developments
  19. 7.4 Huiying Medical
  20. 7.4.1 Huiying Medical Company Information
  21. 7.4.2 Huiying Medical Business Overview
  22. 7.4.3 Huiying Medical Breast AI-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Huiying Medical Breast AI-assisted Diagnosis Software Product Portfolio
  24. 7.4.5 Huiying Medical Recent Developments
  25. 7.5 BioMind
  26. 7.5.1 BioMind Company Information
  27. 7.5.2 BioMind Business Overview
  28. 7.5.3 BioMind Breast AI-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  29. 7.5.4 BioMind Breast AI-assisted Diagnosis Software Product Portfolio
  30. 7.5.5 BioMind Recent Developments
  31. 7.6 Infervision
  32. 7.6.1 Infervision Company Information
  33. 7.6.2 Infervision Business Overview
  34. 7.6.3 Infervision Breast AI-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Infervision Breast AI-assisted Diagnosis Software Product Portfolio
  36. 7.6.5 Infervision Recent Developments
  37. 7.7 Demetics Medical
  38. 7.7.1 Demetics Medical Company Information
  39. 7.7.2 Demetics Medical Business Overview
  40. 7.7.3 Demetics Medical Breast AI-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Demetics Medical Breast AI-assisted Diagnosis Software Product Portfolio
  42. 7.7.5 Demetics Medical Recent Developments
  43. 7.8 GE HealthCare
  44. 7.8.1 GE HealthCare Company Information
  45. 7.8.2 GE HealthCare Business Overview
  46. 7.8.3 GE HealthCare Breast AI-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  47. 7.8.4 GE HealthCare Breast AI-assisted Diagnosis Software Product Portfolio
  48. 7.8.5 GE HealthCare Recent Developments
  49. 7.9 Kheiron
  50. 7.9.1 Kheiron Company Information
  51. 7.9.2 Kheiron Business Overview
  52. 7.9.3 Kheiron Breast AI-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Kheiron Breast AI-assisted Diagnosis Software Product Portfolio
  54. 7.9.5 Kheiron Recent Developments
  55. 7.10 Hologic
  56. 7.10.1 Hologic Company Information
  57. 7.10.2 Hologic Business Overview
  58. 7.10.3 Hologic Breast AI-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Hologic Breast AI-assisted Diagnosis Software Product Portfolio
  60. 7.10.5 Hologic Recent Developments
  61. 7.11 Densitas
  62. 7.11.1 Densitas Company Information
  63. 7.11.2 Densitas Business Overview
  64. 7.11.3 Densitas Breast AI-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Densitas Breast AI-assisted Diagnosis Software Product Portfolio
  66. 7.11.5 Densitas Recent Developments
  67. 7.12 Lunit Inc.
  68. 7.12.1 Lunit Inc. Company Information
  69. 7.12.2 Lunit Inc. Business Overview
  70. 7.12.3 Lunit Inc. Breast AI-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Lunit Inc. Breast AI-assisted Diagnosis Software Product Portfolio
  72. 7.12.5 Lunit Inc. Recent Developments
8 North America
  1. 8.1 North America Breast AI-assisted Diagnosis Software Revenue (2021-2032)
  2. 8.2 North America Breast AI-assisted Diagnosis Software Revenue by Type (2021-2032)
  3. 8.2.1 North America Breast AI-assisted Diagnosis Software Revenue by Type (2021-2026)
  4. 8.2.2 North America Breast AI-assisted Diagnosis Software Revenue by Type (2027-2032)
  5. 8.3 North America Breast AI-assisted Diagnosis Software Revenue Share by Type (2021-2032)
  6. 8.4 North America Breast AI-assisted Diagnosis Software Revenue by Application (2021-2032)
  7. 8.4.1 North America Breast AI-assisted Diagnosis Software Revenue by Application (2021-2026)
  8. 8.4.2 North America Breast AI-assisted Diagnosis Software Revenue by Application (2027-2032)
  9. 8.5 North America Breast AI-assisted Diagnosis Software Revenue Share by Application (2021-2032)
  10. 8.6 North America Breast AI-assisted Diagnosis Software Revenue by Country
  11. 8.6.1 North America Breast AI-assisted Diagnosis Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Breast AI-assisted Diagnosis Software Revenue by Country (2021-2026)
  13. 8.6.3 North America Breast AI-assisted Diagnosis Software Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Breast AI-assisted Diagnosis Software Revenue (2021-2032)
  2. 9.2 Europe Breast AI-assisted Diagnosis Software Revenue by Type (2021-2032)
  3. 9.2.1 Europe Breast AI-assisted Diagnosis Software Revenue by Type (2021-2026)
  4. 9.2.2 Europe Breast AI-assisted Diagnosis Software Revenue by Type (2027-2032)
  5. 9.3 Europe Breast AI-assisted Diagnosis Software Revenue Share by Type (2021-2032)
  6. 9.4 Europe Breast AI-assisted Diagnosis Software Revenue by Application (2021-2032)
  7. 9.4.1 Europe Breast AI-assisted Diagnosis Software Revenue by Application (2021-2026)
  8. 9.4.2 Europe Breast AI-assisted Diagnosis Software Revenue by Application (2027-2032)
  9. 9.5 Europe Breast AI-assisted Diagnosis Software Revenue Share by Application (2021-2032)
  10. 9.6 Europe Breast AI-assisted Diagnosis Software Revenue by Country
  11. 9.6.1 Europe Breast AI-assisted Diagnosis Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Breast AI-assisted Diagnosis Software Revenue by Country (2021-2026)
  13. 9.6.3 Europe Breast AI-assisted Diagnosis Software Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Breast AI-assisted Diagnosis Software Revenue (2021-2032)
  2. 10.2 China Breast AI-assisted Diagnosis Software Revenue by Type (2021-2032)
  3. 10.2.1 China Breast AI-assisted Diagnosis Software Revenue by Type (2021-2026)
  4. 10.2.2 China Breast AI-assisted Diagnosis Software Revenue by Type (2027-2032)
  5. 10.3 China Breast AI-assisted Diagnosis Software Revenue Share by Type (2021-2032)
  6. 10.4 China Breast AI-assisted Diagnosis Software Revenue by Application (2021-2032)
  7. 10.4.1 China Breast AI-assisted Diagnosis Software Revenue by Application (2021-2026)
  8. 10.4.2 China Breast AI-assisted Diagnosis Software Revenue by Application (2027-2032)
  9. 10.5 China Breast AI-assisted Diagnosis Software Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Breast AI-assisted Diagnosis Software Revenue (2021-2032)
  2. 11.2 Asia Breast AI-assisted Diagnosis Software Revenue by Type (2021-2032)
  3. 11.2.1 Asia Breast AI-assisted Diagnosis Software Revenue by Type (2021-2026)
  4. 11.2.2 Asia Breast AI-assisted Diagnosis Software Revenue by Type (2027-2032)
  5. 11.3 Asia Breast AI-assisted Diagnosis Software Revenue Share by Type (2021-2032)
  6. 11.4 Asia Breast AI-assisted Diagnosis Software Revenue by Application (2021-2032)
  7. 11.4.1 Asia Breast AI-assisted Diagnosis Software Revenue by Application (2021-2026)
  8. 11.4.2 Asia Breast AI-assisted Diagnosis Software Revenue by Application (2027-2032)
  9. 11.5 Asia Breast AI-assisted Diagnosis Software Revenue Share by Application (2021-2032)
  10. 11.6 Asia Breast AI-assisted Diagnosis Software Revenue by Country
  11. 11.6.1 Asia Breast AI-assisted Diagnosis Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Breast AI-assisted Diagnosis Software Revenue by Country (2021-2026)
  13. 11.6.3 Asia Breast AI-assisted Diagnosis Software Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Breast AI-assisted Diagnosis Software Revenue (2021-2032)
  2. 12.2 SAMEA Breast AI-assisted Diagnosis Software Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Breast AI-assisted Diagnosis Software Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Breast AI-assisted Diagnosis Software Revenue by Type (2027-2032)
  5. 12.3 SAMEA Breast AI-assisted Diagnosis Software Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Breast AI-assisted Diagnosis Software Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Breast AI-assisted Diagnosis Software Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Breast AI-assisted Diagnosis Software Revenue by Application (2027-2032)
  9. 12.5 SAMEA Breast AI-assisted Diagnosis Software Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Breast AI-assisted Diagnosis Software Revenue by Country
  11. 12.6.1 SAMEA Breast AI-assisted Diagnosis Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Breast AI-assisted Diagnosis Software Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Breast AI-assisted Diagnosis Software Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst